Ceesay Abraham
- SEC CIK
- 0001722140
In the past year, 12 open-market sale filings worth $6.07M and no purchases.
Current role at each company
- RAPP Rapport Therapeutics, Inc.Chief Executive Officeras of Sep 24, 2026
- CRL Charles River Laboratories International, Inc.Directoras of May 11, 2026
- PCRX Pacira BioSciences, Inc.Directoras of Sep 8, 2025
- CERE Cerevel Therapeutics Holdings, Inc.Presidentas of Feb 8, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $6.07M
- 12 filings
- Net
- −$6.07M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Ceesay Abraham as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RAPP Rapport Therapeutics, Inc.
Chief Executive Officer19 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 (view filing)4:05 PM ET | Sep 23 | 1 day | Ceesay AbrahamChief Executive Officer | SSale | −2.21K | $39.17 | −$86.6K | −0.5%456.8K after | 3 lots10b5-1 |
| Sep 9, 2026 (view filing)4:05 PM ET | Sep 8 | 1 day | Ceesay AbrahamChief Executive Officer | SSale | −8.21K | $45.61 | −$374.5K | −1.8%459.0K after | 2 lots10b5-1 |
| Aug 26, 2026 (view filing)4:05 PM ET | Aug 25 | 1 day | Ceesay AbrahamChief Executive Officer | SSale | −18.9K | $49.57 | −$938.0K | −3.9%467.2K after | 10b5-1 |
| Aug 12, 2026 (view filing)4:35 PM ET | Aug 10-11 | 2 days | Ceesay AbrahamChief Executive Officer | SSale | −51.5K | $47.25 | −$2.43M | −9.6%486.1K after | 5 lots10b5-1 |
| Jul 29, 2026 (view filing)4:05 PM ET | Jul 27 | 2 days | Ceesay AbrahamChief Executive Officer | SSale | −2.21K | $42.11 | −$93.1K | −0.4%537.6K after | 2 lots10b5-1 |
| Jul 15, 2026 (view filing)4:15 PM ET | Jul 14 | 1 day | Ceesay AbrahamChief Executive Officer | SSale | −8.21K | $40.00 | −$328.4K | −1.5%539.8K after | 2 lots10b5-1 |
| Jul 1, 2026 (view filing)4:05 PM ET | Jun 29 | 2 days | Ceesay AbrahamChief Executive Officer | SSale | −8.22K | $39.83 | −$327.4K | −1.5%548.0K after | 2 lots10b5-1 |
| Feb 19, 2026 (view filing) | Feb 18 | 1 day | Ceesay AbrahamChief Executive Officer | SSale | −5.83K | $29.34 | −$171.2K | −1.0%556.2K after | 2 lots10b5-1 |
| Feb 19, 2026 (view filing) | Feb 18 | 1 day | Ceesay AbrahamChief Executive Officer | SSale | −5.08K | $29.35 | −$149.2K | −19.7%20.7K after | 2 lots10b5-1 |
| Jan 22, 2026 (view filing) | Jan 20 | 2 days | Ceesay AbrahamChief Executive Officer | SSale | −5.83K | $26.12 | −$152.4K | −1.0%562.1K after | 10b5-1 |
PCRX Pacira BioSciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2025 (view filing) | Sep 4 | 4 days | Ceesay AbrahamDirector | SSale | −2.35K | $27.19 | −$64.0K | −20.7%9.04K after | 10b5-1 |
CERE Cerevel Therapeutics Holdings, Inc.
President4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2022 (view filing) | Sep 8 | 4 days | Ceesay AbrahamPresident | SSale | −19.2K | $32.50 | −$624.3K | −100.0%0 after | |
| Aug 24, 2022 (view filing) | Aug 22 | 2 days | Ceesay AbrahamPresident | SSale | −9.61K | $32.50 | −$312.2K | −100.0%0 after | |
| Aug 17, 2022 (view filing) | Aug 15 | 2 days | Ceesay AbrahamPresident | SSale | −9.61K | $34.12 | −$327.8K | −100.0%0 after | |
| Aug 9, 2022 (view filing) | Aug 5-8 | 4 days | Ceesay AbrahamPresident | SSale | −57.6K | $34.54 | −$1.99M | −100.0%0 after | 3 lots |